INFRATIL LIMITED (IFT)
Share Price Analysis and Chart

Enter the company code or Name for stock analysis:

IFT

IFT - INFRATIL LIMITED

FNArena Sector : Wealth Management & Investments
Year End: March
GICS Industry Group : Capital Goods
Debt/EBITDA: 20.91
Index: ASX200 | ASX300 | ALL-ORDS

LAST PRICE CHANGE +/- CHANGE % VOLUME

$12.44

07 May
2026

0.370

OPEN

$12.20

3.07%

HIGH

$12.56

861,574

LOW

$12.20

TARGET
$12.085 -2.9% downside
OTHER COMPANIES IN THE SAME SECTOR
AEF . AMP . ASX . BVS . CGF . CVW . DJW . ENN . GDG . GQG . HMC . HUB . IRE . KAM . KSL . MAF . MFG . MQG . NGI . NWL . PAC . PNI . PPS . PPT . QAL . RPL . RZI . WHF .
FNARENA'S MARKET CONSENSUS FORECASTS
IFT: 1
Title FY24
Actual		 FY25
Actual		 FY26
Forecast		 FY27
Forecast
EPS (cps) xxx - 27.9 19.9 xxx
DPS (cps) xxx 18.7 18.4 xxx
EPS Growth xxx N/A N/A xxx
DPS Growth xxx - 5.6% - 1.4% xxx
PE Ratio xxx N/A 62.2 xxx
Dividend Yield xxx N/A 1.5% xxx
Div Pay Ratio(%) xxx N/A 92.3% xxx

Dividend yield today if purchased 3 years ago: N/A

DIVIDEND YIELD CALCULATOR

Dividend Yield Today On Last Actual Payout :

 N/A

Estimated Dividend Growth
(Average Of Past Three Years)

  %

Amount Invested

 $ 

Tell Me The Dividend After This Many Years
Past performance is no guarantee for the future. Investors should take into account that heavy swings in share price or exceptional circumstances (a la 2009) can have a significant impact on short term calculations and averages

Last ex-div: 26/11 - (franking ex-div 8c)

HISTORICAL DATA ARE ALL IN AUD
Copyright © 2026 FactSet UK Limited. All rights reserved
Title 202020212022202320242025
EPS Basic xxxxxxxxxxxxxxx-27.9
DPS All xxxxxxxxxxxxxxx18.7
Sales/Revenue xxxxxxxxxxxxxxx2,945.6 M
Book Value Per Share xxxxxxxxxxxxxxx625.4
Net Operating Cash Flow xxxxxxxxxxxxxxx351.7 M
Net Profit Margin xxxxxxxxxxxxxxx-8.85 %

EPS Basic

DPS All

Sales/Revenue

Book Value Per Share

Net Operating Cash Flow

Net Profit Margin

Title 202020212022202320242025
Return on Capital Employed xxxxxxxxxxxxxxx-4.54 %
Return on Invested Capital xxxxxxxxxxxxxxx-2.24 %
Return on Assets xxxxxxxxxxxxxxx-1.68 %
Return on Equity xxxxxxxxxxxxxxx-4.54 %
Return on Total Capital xxxxxxxxxxxxxxx-1.94 %
Free Cash Flow ex dividends xxxxxxxxxxxxxxx-176.9 M

Return on Capital Employed

Return on Invested Capital

Return on Assets

Return on Equity

Return on Total Capital

Free Cash Flow ex dividends

Title 202020212022202320242025
Short-Term Debt xxxxxxxxxxxxxxx381 M
Long Term Debt xxxxxxxxxxxxxxx6,025 M
Total Debt xxxxxxxxxxxxxxx6,407 M
Goodwill - Gross xxxxxxxxxxxxxxx4,255 M
Cash & Equivalents - Generic xxxxxxxxxxxxxxx267 M
Price To Book Value xxxxxxxxxxxxxxx1.51

Short-Term Debt

Long Term Debt

Total Debt

Goodwill - Gross

Cash & Equivalents - Generic

Price To Book Value

Title 202020212022202320242025
Capex xxxxxxxxxxxxxxx544.6 M
Capex % of Sales xxxxxxxxxxxxxxx18.49 %
Cost of Goods Sold xxxxxxxxxxxxxxx2,470 M
Selling, General & Admin. Exp & Other xxxxxxxxxxxxxxx738 M
Research & Development xxxxxxxxxxxxxxx-
Investments - Total xxxxxxxxxxxxxxx432 M

Capex

Capex % of Sales

Cost of Goods Sold

Selling, General & Admin. Exp & Other

Research & Development

Investments - Total

EXPERT VIEWS
Display All Commentary

Sentiment Indicator

0.9

No. Of Recommendations

5
BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Macquarie

xx/xx/xxxx

1

xxxxxxxxxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Citi

xx/xx/xxxx

1

xxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

UBS

07/05/2026

1

Buy

-

-

UBS details how Infratil had decoupled from the CDC valuation earlier in 2026 to a valuation gap of over -NZ$2bn.

Post the CDC announcement of a 30-year contract with a large US hyperscaler for 555MW, the valuation gap has shrunk to less than -NZ$2bn.

The current share price around NZ$14.55 infers the Infratil stake is valued around NZ$9bn, which aligns with the independent valuation but sits -15% below the analyst's updated valuation of NZ$10.7bn.

The broker believes the market is not fully appreciating the 'Densification Dividend' that CDC should be able to generate over the next five years.

Further contract announcements are flagged at FY26 results on May 26. Buy rated. Target lifts to NZ$16.50.

FORECAST
UBS forecasts a full year FY26 dividend of 18.41 cents.
UBS forecasts a full year FY27 dividend of 18.41 cents.

Morgan Stanley

xx/xx/xxxx

1

xxxxxxxxxx

-

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial

Morgans

xx/xx/xxxx

2

xxxxxxxxxx xx xxxxxxxx xxxx xxxxxxxxxx

$xx.xx

xx.xx%

Broker commentary and detailed analysis is available for Full Members Only.
Login above or Get a Free Trial
Access Stockbroker Research History >
EXTRA COVERAGE
Display All Commentary

No. Of Recommendations

1

Please note: unlike Broker Call Report, BC Extra is not updated daily. The info you see might not be the latest. FNArena does its best to update ASAP.

BROKER DATE RATING RECOMMENDATION TARGET PRICE % TO REACH TARGET COMMENTARY

Jarden

09/05/2026

1

Buy

$14.56

17.04%

Jarden retains a Buy rating and unchanged NZ$14.56 target price for Infratil Limited following the announcement of a massive 555MW data centre contract secured by its CDC Data Centres business.

The 30-year agreement with an investment-grade US customer represents the largest data contract in Australian history and pushes CDC's total contracted capacity beyond 1GW.

Earnings contributions from the new capacity will commence as operations scale across FY28 and FY29, supported by the company's existing development program.

Management reaffirmed FY27 EBITDAF guidance of A$680m to A$720m while forecasting a step-change in earnings to exceed A$1bn in FY28.

The broker views the scale of this contract as a major validation of the underlying investment thesis, projecting annualised EBITDAF to approach A$2bn once fully deployed.
Access Extra Coverage Research History >

IFT STOCK CHART

FNArena News on IFT

1
Artificial Intelligence: Here, There & Everywhere

May 07 2026 - Australia
2
Rudi’s View: AI, The Great Market Divider

May 06 2026 - Rudi's View
3
AI’s Power Demand Is Rewiring Global Markets

Apr 27 2026 - Commodities
4
Australian Broker Call *Extra* Edition – Mar 30, 2026

Mar 30 2026 - Daily Market Reports
5
Australian Broker Call *Extra* Edition – Nov 19, 2025

Nov 19 2025 - Daily Market Reports

Latest Wealth Management & Investments News

1
Capital Markets: How AI Is Changing The Game

May 08 2026 - International
2
Weekly Update On LICs & LITs – 06-May-2026

May 06 2026 - Weekly Reports
3
Macquarie Shares Poised For New Highs

May 05 2026 - Technicals
4
Rising Regulatory Risk for Hub24 & Netwealth?

Apr 29 2026 - Australia
5
Too Much Property, Not Enough Equities?

Apr 28 2026 - SMSFundamentals
6
Weekly Update On LICs & LITs – 28-Apr-2026

Apr 28 2026 - Weekly Reports
7
Weekly Update On LICs & LITs – 21-Apr-2026

Apr 21 2026 - Weekly Reports
8
Weekly Update On LICs & LITs – 14-Apr-2026

Apr 14 2026 - Weekly Reports
9
Weekly Update On LICs & LITs – 08-Apr-2026

Apr 08 2026 - Weekly Reports
10
Opportunity In ‘Mini Macquarie’ Weakness

Mar 31 2026 - Small Caps